Latest period
$240.00M
YoY change
+19.9%
5Y CAGR
+21.1%
Peak year (2025)
$247.00M
Latest annual
$247.00M
Stock-Based Compensation history chart for IQVIA (IQV) from 2010 to 2025
Latest: $247.00M
Stock-Based Compensation growth chart for IQVIA (IQV) from 2010 to 2025
Latest: +19.9%
Stock-Based Compensation history table for IQVIA (IQV) from 2010 to 2025
| 2025 | $247.00M | +19.9% | +$41.00M | ||
| 2024 | $206.00M | -5.1% | −$11.00M | ||
| 2023 | $217.00M | +11.9% | +$23.00M | ||
| 2022 | $194.00M | +14.1% | +$24.00M | ||
| 2021 | $170.00M | +78.9% | +$75.00M | ||
| 2020 | $95.00M | -34.9% | −$51.00M | ||
| 2019 | $146.00M | +29.2% | +$33.00M | ||
| 2018 | $113.00M | +6.6% | +$7.00M | ||
| 2017 | $106.00M | +32.5% | +$26.00M | ||
| 2016 | $80.00M | +111.9% | +$42.24M | ||
| 2015 | $37.76M | +25.9% | +$7.76M | ||
| 2014 | $30.00M | +31.4% | +$7.17M | ||
| 2013 | $22.83M | -12.0% | −$3.10M | ||
| 2012 | $25.93M | +83.5% | +$11.80M | ||
| 2011 | $14.13M | -18.5% | −$3.20M | ||
| 2010 | $17.33M | — | — |
- 2025$247.00M+19.9%
- 2024$206.00M-5.1%
- 2023$217.00M+11.9%
- 2022$194.00M+14.1%
- 2021$170.00M+78.9%
- 2020$95.00M-34.9%
- 2019$146.00M+29.2%
- 2018$113.00M+6.6%
- 2017$106.00M+32.5%
- 2016$80.00M+111.9%
- 2015$37.76M+25.9%
- 2014$30.00M+31.4%
- 2013$22.83M-12.0%
- 2012$25.93M+83.5%
- 2011$14.13M-18.5%
- 2010$17.33M—
Stock-Based Compensation values are taken from IQVIA's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at IQVIA (IQV)
Stock-Based Compensation for IQVIA (IQV): headline value $240.00M · YoY +19.9%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, IQVIA (IQV) reported stock-based compensation of $247.00M – grew 19.9% year-over-year.
Across 2020–2025 (5 years), IQVIA stock-based compensation produced a CAGR of +21.1% – with mixed annual results across the window.
The highest annual stock-based compensation of $247.00M was reported in 2025. The lowest in the available history was $14.13M in 2011.
IQVIA Stock-Based Compensation by Year
IQVIA Stock-Based Compensation 2025: $247.00M
IQVIA posted stock-based compensation of $247.00M in 2025, grew 19.9% from 2024. This figure represents the highest annual value in the available history.
IQVIA Stock-Based Compensation 2024: $206.00M
In 2024, IQVIA reported stock-based compensation of $206.00M, declined 5.1% below 2023.
IQVIA Stock-Based Compensation 2023: $217.00M
IQVIA stock-based compensation in 2023 was $217.00M, grew 11.9% from 2022.
IQVIA Stock-Based Compensation 2022: $194.00M
2022's stock-based compensation for IQVIA came in at $194.00M, grew 14.1% from 2021.
IQVIA Stock-Based Compensation 2021: $170.00M
IQVIA stock-based compensation in 2021 was $170.00M.
See more financial history for IQVIA (IQV).
Sector peers by Stock-Based Compensation
Healthcare peers of IQVIA (IQV), ranked by their latest stock-based compensation
| $1.35B | |
| $971.00M | |
| $955.00M | |
| $626.00M | |
| $0.00 | |
| $0.00 | |
| $0.00 | |
| $0.00 |
- $1.35B
- $971.00M
- $955.00M
- $626.00M
- $0.00
- $0.00
- $0.00
- $0.00
Frequently asked questions
IQVIA (IQV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation